Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2008-01-01 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLENEUVE-DE-LA-RAHO (66180), Pyrenees-Orientales
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DE LA RAHO : revenue, balance sheet and financial ratios
SELAS PHARMACIE DE LA RAHO is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLENEUVE-DE-LA-RAHO (66180),
this company of category PME
shows in 2022 a revenue of 3.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DE LA RAHO (SIREN 501971394)
Indicator
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
3 823 593 €
N/C
N/C
N/C
N/C
Net income
513 793 €
141 656 €
227 445 €
179 489 €
231 151 €
204 866 €
140 615 €
EBITDA
N/C
N/C
363 181 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
5.9%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELAS PHARMACIE DE LA RAHO generates positive net income of 514 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 141 k€ -> 514 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
513 793 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 460%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 15%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
459.722%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
15.433%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DE LA RAHO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Debt ratio
287.101
218.716
196.653
160.543
134.073
106.511
459.722
Financial autonomy
23.83
28.781
30.679
34.353
38.195
41.959
15.433
Repayment capacity
None
None
None
None
8.005
None
None
Cash flow / Revenue
None%
None%
None%
None%
7.006%
None%
None%
Sector positioning
Debt ratio
459.722024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+11 pts over 3 years
In 2024, the debt ratio of SELAS PHARMACIE DE LA RAHO (459.72) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
15.43%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch-14 pts over 3 years
In 2024, the financial autonomy of SELAS PHARMACIE DE LA RAHO (15.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
8.01 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELAS PHARMACIE DE LA RAHO (8.01) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 256.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
256.538
Liquidity indicators evolution SELAS PHARMACIE DE LA RAHO
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
314.933
313.684
392.396
334.601
297.619
233.176
256.538
Interest coverage
None
None
None
None
4.756
None
None
Sector positioning
Liquidity ratio
256.542024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good
In 2024, the liquidity ratio of SELAS PHARMACIE DE LA RAHO (256.54) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
4.76x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of SELAS PHARMACIE DE LA RAHO (4.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE DE LA RAHO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
726 827 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
38
0
0
Customer payment term (days)
0
0
0
0
1
0
0
Supplier payment term (days)
0
0
0
0
47
0
0
Positioning of SELAS PHARMACIE DE LA RAHO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE DE LA RAHO is estimated at
7 172 930 €
(range 4 995 115€ - 10 731 113€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
4995k€7172k€10731k€
7 172 930 €Range: 4 995 115€ - 10 731 113€
NAF 5 année 2024
Valuation method used
Net Income Multiple
513 793 €
×
14.0x
=7 172 930 €
Range: 4 995 115€ - 10 731 114€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DE LA RAHO with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DE LA RAHO
What is the revenue of SELAS PHARMACIE DE LA RAHO ?
The revenue of SELAS PHARMACIE DE LA RAHO in 2022 is 3.8 M€.
Is SELAS PHARMACIE DE LA RAHO profitable?
Yes, SELAS PHARMACIE DE LA RAHO generated a net profit of 514 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE DE LA RAHO ?
The headquarters of SELAS PHARMACIE DE LA RAHO is located in VILLENEUVE-DE-LA-RAHO (66180), in the department Pyrenees-Orientales.
Where to find the tax return of SELAS PHARMACIE DE LA RAHO ?
The tax return of SELAS PHARMACIE DE LA RAHO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DE LA RAHO operate?
SELAS PHARMACIE DE LA RAHO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart